A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2011
08/10/2011	CN102144984A Easy-dissolution lamivudine tablet and preparation method thereof
08/10/2011	CN102144983A Entecavir dispersible tablets and preparation method thereof
08/10/2011	CN102144975A Cefprozil suspension pharmaceutical composition
08/10/2011	CN102144972A Podophyllotoxin ethosomes and preparation methods thereof
08/10/2011	CN102144967A Veterinary long-acting compound doxycycline injection and preparation method thereof
08/10/2011	CN102144966A Preparation method of clindamycin phosphate injection
08/10/2011	CN102144962A Powdered osletamirvir phosphate medicinal composition
08/10/2011	CN101974068B Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof
08/10/2011	CN101884701B Medicament for treating herpes zoster
08/10/2011	CN101851304B Production process for manufacturing solid-phase povidone iodine
08/10/2011	CN101810733B Chinese medicinal composition for curing bouine mastitis and preparation method and application thereof
08/10/2011	CN101804114B Medicine composition for treating infantile parotitis and preparation method thereof
08/10/2011	CN101797305B Natural plant composition for treating skin disease of tinea pedis
08/10/2011	CN101780162B Traditional Chinese medicine for treating hepatitis A
08/10/2011	CN101732522B Plaster for treating osteonecrosis of the femoral head, osseous tuberculosis, osteomyelitis and osteoma
08/10/2011	CN101700292B Traditional Chinese medicine composite for curing lymphatic tuberculosis
08/10/2011	CN101690640B Drug curtain cloth preventing influenza A H1N1 and preparation method
08/10/2011	CN101648993B Small peptide A with antibacterial and antitumor functions and applications thereof
08/10/2011	CN101619068B Novel method for preparing marbofloxacin
08/10/2011	CN101612203B Traditional Chinese medicine composition used for treating pointed condyloma and application thereof
08/10/2011	CN101596252B Composition for treating herpes zoster and preparation method thereof
08/10/2011	CN101544634B 2-phenyl-3-substituted pyrazolo[1,5-a]pyridine derivatives, preparation method and application thereof
08/10/2011	CN101531680B Method for synthesizing (R)-9(2-(diethyl phosphonyl methoxyl) propyl)-adenine
08/10/2011	CN101503472B Human source neutralizing antibody specific against botulinum neurotoxin type A and use thereof
08/10/2011	CN101502501B Anti-infective medicament composition and application
08/10/2011	CN101497557B Method for extracting purified solanesol from potato leaf
08/10/2011	CN101422481B Use of Eupatorium adenophorum polysaccharide for antibiosis or antivirus
08/10/2011	CN101417018B Preparation method of animal injection capable of clearing away the heat-evil and expelling superficial evils, cooling blood and relieving dysentery
08/10/2011	CN101394868B Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector
08/10/2011	CN101367805B Formyl guanidino substituted sulfhydryl pyrrolidine carbpenem compounds
08/10/2011	CN101327313B Oral medication for treating epigastric pain
08/10/2011	CN101327235B Use of pseudo-ginseng saponins for treating septicemia
08/10/2011	CN101259197B Medicinal composition for treating cold and preparation thereof
08/10/2011	CN101239065B Method for preparing cefepime dihydrochloride and L-arginine mixed powder
08/10/2011	CN101224252B External Chinese patent medicine for treating tinea
08/10/2011	CN101190211B Application of aromatic nitro compound in preparing medicine for treating virus hepatitis
08/10/2011	CN101148466B RNA disturbance target point for inhibiting MDV proliferating and application thereof
08/10/2011	CN101054408B Method for separating housefly secretion type antibacterial peptide, product and application thereof
08/09/2011	US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans
08/09/2011	US7994318 Coumarin derivatives useful as TNFα inhibitors
08/09/2011	US7994282 Card proteins involved in cell death regulation
08/09/2011	US7994219 Approach to anti-microbial host defense with molecular shields with lipoxin compounds
08/09/2011	US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
08/09/2011	US7994154 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
08/09/2011	US7994152 Method of treating a cancer by administering A 2′,5′-oligoadenylate analog
08/09/2011	US7994145 Bicyclonucleoside analogues
08/09/2011	US7994144 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme
08/09/2011	US7993878 Antibodies to human IL-1β
08/09/2011	US7993676 Free-flowing, powdery composition containing alpha-liponic acid (derivates)
08/09/2011	US7993651 Administering gag protein; vaccines for human immunodeficiency virus
08/09/2011	CA2607359C Compounds and methods for the treatment or prevention of flavivirus infections
08/09/2011	CA2596994C Hydroalcoholic antimicrobial composition with skin health benefits
08/09/2011	CA2591846C Oral compositions containing biphenol antibacterial compounds
08/09/2011	CA2500712C Antibiotic pharmaceutical composition with improved oral absorbability
08/09/2011	CA2487727C Compounds useful in the treatment of anthrax and inhibiting lethal factor
08/09/2011	CA2468419C Disinfectant solutions consisting essentially of a tetrasodium edta salt and a solvent and use thereof for disinfection
08/09/2011	CA2445190C Indole, azaindole and related heterocyclic amidopiperazine derivatives
08/09/2011	CA2432568C Benzoylpyridazines
08/09/2011	CA2409209C Chimeric arterivirus-like particles
08/09/2011	CA2405958C Hybrid glycosylated products and their production and use
08/09/2011	CA2370738C Uteroglobin in the treatment of iga mediated autoimmune disorders
08/09/2011	CA2366462C Two-step immunization procedure against chlamydia infection
08/09/2011	CA2332115C Aav structural protein, its preparation and use
08/04/2011	WO2011094657A2 Additives for chlorine dioxide-containing compositions
08/04/2011	WO2011094426A1 Caspase inhibitors
08/04/2011	WO2011094290A1 Pyrazolopyrimidine kinase inhibitors
08/04/2011	WO2011093932A2 Design of fibrinogen and fibrinogen derived products with reduced bacterial binding by using modified sequences of fibrinogen chains
08/04/2011	WO2011093825A2 Effervescent dosage forms comprising cephalosporin antibiotic
08/04/2011	WO2011093823A2 Effervescent formulations comprising cefaclor and clavulanic acid
08/04/2011	WO2011093810A2 Dry powder pharmaceutical composition comprising tiotropium and mometasone
08/04/2011	WO2011093783A1 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
08/04/2011	WO2011093483A1 Therapeutic agent for hepatitis c
08/04/2011	WO2011093294A1 Process for preparation of cephalosporin derivative
08/04/2011	WO2011092675A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
08/04/2011	WO2011092655A2 Mentha suaveolens essential oil and therapeutic activities thereof
08/04/2011	WO2011092551A1 Antimicrobial composition
08/04/2011	WO2011092294A1 Extracellular ifi16 as therapeutic agents
08/04/2011	WO2011091778A1 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes
08/04/2011	WO2011091757A1 Polyheterocyclic compounds highly potent as hcv inhibitors
08/04/2011	WO2011091719A1 Crystalline hydrates of alkyl acyl acetaldehyde sulfite, preparation methods and uses thereof
08/04/2011	WO2011091614A1 7-(2-substituted-3-amino-1-tetrahydropyrrolo[3,4-c]pyrazolyl)quinoline carboxylic acid derivatives, their preparation methods and uses against bacterium and tuberculosis
08/04/2011	WO2011091532A1 Hepatitis c inhibitor compounds
08/04/2011	WO2011038313A3 Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase
08/04/2011	WO2011032000A9 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide
08/04/2011	WO2011031073A3 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
08/04/2011	WO2011022725A3 Mimotopes of hiv and uses thereof
08/04/2011	WO2011005595A3 2-5a analogs and their methods of use
08/04/2011	WO2008133534A3 Carbohydrate-lipid constructs and their use in preventing or treating viral infection
08/04/2011	US20110191915 Influenza virus immunizing epitope
08/04/2011	US20110191872 Method for the humanization of antibodies and humanized antibodies thereby obtained
08/04/2011	US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy
08/04/2011	US20110190474 Antimicrobial peptides and derived metapeptides
08/04/2011	US20110190399 Curcumin nanoparticles and methods of producing the same
08/04/2011	US20110190392 Polysaccharide Based Antimicrobial Formulations
08/04/2011	US20110190385 Methods and Products for Reawakening Retrocyclins
08/04/2011	US20110190343 Hiv-1 fusion inhibitors and methods
08/04/2011	US20110190342 Glycine b antagonist
08/04/2011	US20110190325 Compounds, their syntheses, and thier uses
08/04/2011	US20110190314 Pharmaceutical compositions and their methods of use
08/04/2011	US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents

1 ... 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 ... 1798